An interventional study of Exercise Intervention and Informational Intervention in High-Frequency Microsatellite Instability, Mismatch Repair Gene Mutation and Mutation-Negative Lynch Syndrome, sponsored by M.D. Anderson Cancer Center. Completed at 1 site in United States. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2024-01-05.
Sponsored by M.D. Anderson Cancer Center · Not applicable, Interventional, and Prevention
This trial studies how well cycling works in preventing colorectal cancer in participants with Lynch syndrome. Exercise such as cycling may reduce colorectal cancer risk in participants with Lynch syndrome.
PRIMARY OBJECTIVES:
I. To assess the feasibility of a 12-month exercise cycling intervention among Lynch syndrome (LS) patients.
SECONDARY OBJECTIVES:
I. To assess the effect size of exercise on circulating biomarkers as well as regulation of genomic, transcriptomic, and immunologic biomarkers in normal intestinal mucosa of LS patients.
OUTLINE: Participants are assigned to 1 of 2 groups.
GROUP I: Starting on day 15, participants wear FITBIT and complete cycling classes over 45 minutes 3 times a week for a total of 12 classes a month for up to 1 year.
GROUP II: Starting on day 15, participants receive information about exercise guidelines and wear FITBIT to track heart rate and activities for up to 1 year.
After completion of study interventions, participants are followed up at 30 days.
Exclusion Criteria:
Starting on day 15, participants wear FITBIT and complete cycling classes over 45 minutes 3 times a week for a total of 12 classes a month for up to 1 year.
Behavioral: Exercise Intervention · Device: Monitoring Device · Other: Questionnaire Administration
Starting on day 15, participants receive information about exercise guidelines and wear FITBIT to track heart rate and activities for up to 1 year.
Other: Informational Intervention · Device: Monitoring Device · Other: Questionnaire Administration
Complete cycling classes
Receive information about exercise guidelines
Wear Fitbit
Also known as: Monitor
Complete questionnaire
Recruitment rate
Defined as the proportion of eligible patients who consent to the number of patients who are contacted. This study will be considered as feasible if the recruitment rate is at least 20%.
Time frame: Up to 1 year
Adherence rate
Defined as the proportion of the actual attendance number to the planned number of exercise sessions (12 sessions monthly x 12 months) where patients will be required to comply with duration (time) of each session participated as well as monthly attendance. This study will be considered as feasible if the adherence rate is at least 75%.
Time frame: Up to 1 year
Retention
Defined as the proportion of participants who stay until study completion. This study will be considered as feasible if the retention rate is at least 75%.
Time frame: Up to 1 year
This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Colorectal Neoplasms, Hereditary Nonpolyposis→
M.D. Anderson Cancer Center